Activation of interferon regulatory factor 3 by replication-competent vaccinia viruses improves antitumor efficacy mediated by T cell responses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activation of interferon regulatory factor 3 by replication-competent vaccinia viruses improves antitumor efficacy mediated by T cell responses

Published:2021-09 Issue: Volume:22 Page:399-409
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Riederer Stephanie,Fux Robert,Lehmann Michael H.,Volz Asisa,Sutter Gerd,Rojas Juan J.

Funder

Spanish Scientific Research Council

Instituto de Neurobiologia Ramon y Cajal

Stiftung Deutsche Krebshilfe

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference53 articles.

1. Oncology meets immunology: The cancer-immunity cycle;Chen;Immunity,2013

2. Cancer immunoediting: Integrating immunity’s roles in cancer suppression and promotion;Schreiber;Science,2011

3. Cancer immunotherapy: Harnessing the immune system to battle cancer;Yang;J. Clin. Invest.,2015

4. Targeting cancer-related inflammation in the era of immunotherapy;Nakamura;Immunol. Cell Biol.,2017

5. Immune checkpoint inhibitors: Recent progress and potential biomarkers;Darvin;Exp. Mol. Med.,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses;Molecular Therapy;2024-07

2. Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy;International Journal of Molecular Sciences;2024-04-25

3. Tumor Tropism of DNA Viruses for Oncolytic Virotherapy;Viruses;2023-11-16

4. Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease;Cancer Gene Therapy;2023-04-04

5. Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics;Current Opinion in Chemical Biology;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3